Published in:
Open Access 01-08-2021 | Apixaban | Correction
Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY
Published in: Advances in Therapy | Issue 8/2021
Login to get accessExcerpt
In the original article, Figure 1 was published incorrectly. The correct Fig. 1 is given below.
Fig. 1
Recurrent VTE or VTE-related death, major bleeding, and composite of major or CRNM bleeding during the treatment period by body weight category. CI confidence interval, CRNM clinically relevant non-major, NE not estimable, RR relative risk, VTE venous thromboembolism
× ![]()
…